seek in Biological Technology

Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company

EMERYVILLE, Calif., March 26 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) announced today that it has hired RBC Capital Markets as its exclusive financial advisor to assist in the evaluation of various options to enhance shareholder value, including a pot...

Insmed to Seek Shareholder Approval for Reverse Split

RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq CM: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it will seek shareholder approval to implement a reverse stock split, if necessary, at a Special Meeting of Stockholders on November 2...

PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application

EDISON, N.J., Sept. 1 /PRNewswire/ -- PSKW, LLC, a New Jersey-based leading provider of prescription co-pay programs for the pharmaceutical industry, announced today that it has significantly expanded the scope of the lawsuit that it commenced last year in the Supreme Court of the State of New...

Concerned Shareholders of Biovail seek court order declaring Biovail AGM illegally convened;

Say Biovail seeing tide changing against management - with six million votes revoked - and no quoroum at meeting, secretly met to change rules TORONTO, June 25 /PRNewswire/ - The Concerned Shareholders of Biovail (TSE:BVF) said that their lawyers will be in court today and will seek a decla...

EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting

ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that the Company's Board of Directors has decided against seeking stockhold...

Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)

WALTHAM, Mass., April 15 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC Bulletin Board: ABOS) today announced that it has commenced the marketing authorization process in the European Union to pursue CE Marking the SEPET(TM) Liver Assist Device. The Company has engaged the British Standar...

Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden

PLANTATION, Fla., Sept. 14 /PRNewswire-FirstCall/ -- Viragen, Inc. (OTC Bulletin Board: VRAI) and its majority-owned subsidiary, Viragen International, Inc. (OTC Bulletin Board: VRGE), today jointly announced that Viragen International's wholly-owned subsidiary, ViraNative AB, located in Umea,...

Chrome Group to Seek Listing for Some of its Subsidiaries

ABUJA, August 20 /PRNewswire/ -- The Chrome Group today announced its plans to seek a listing of at least two of its companies on trading platforms in Europe and the Middle East. In a statement released in Abuja today, the Group Chief Communications Officer, Mr. Val Oji said that "this was par...

Wisconsin investors seek regional partners and informed legislature

The Coalition for Capital Growth and Research held their conference at Grainger Hall. Madison, Wis. Regional cooperation is the way to attract venture capital to Wisconsin, according to the Coalition for Capital Growth and Research, which held its first conference on Friday at UW-Madisons Gra...

Third Wave to seek FDA clearences after expanding pipeline

Madison, Wis. Third Wave Technologies has expanded its product pipeline and will seek FDA clearance for several products within the next few years, the company told investors and analysts on Thursday. Third Wave, based in Madison, makes molecular genetic diagnostics. The company said revenu...

WARF, UW-Madison seek designer for the Wisconsin Institutes for Discovery

Madison, Wis. - The Wisconsin Alumni Research Foundation and the University of Wisconsin-Madison are requesting proposals for the design of the Wisconsin Institutes for Discovery, the $150 million collaborative research facility to be built on the UW-Madison campus. All qualified parties ...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... we will have to substantially reduce our operations to preserve capital or seek bankruptcy protection or otherwise wind up our business. In additio...ts to enter into alliances and licensing agreements, we plan to continue to seek access to the capital markets to fund our operations. We filed a shelf regi...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...development plans once they are developed." McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek governmental grants from the National Institutes of Health ("NIH"), the National Institute on Drug Abuse, and other agencies that operate under the NI...

Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305

...apital that we expect will allow us to continue to seek to internally develop CUDC-101, our first-in-class...innovative signalling pathway drug technologies to seek to create new medicines for cancer indications. In...d benefits of the agreement; Debiopharm's plans to seek approval for the commencement of a phase I clinica...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...l capillary GL-3, the substrate that accumulates in the cells of Fabry patients. In addition, the FDA is in agreement that the Company is eligible to seek Accelerated Approval for Amigal according to Subpart H regulations. Amicus has begun submitting the Phase 3 protocol to investigational sites worldwid...

ADVENTRX Pharmaceuticals Announces Financing

...risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to continue as a going concern; the risk that ADVENTRX will seek protection under the provisions of the U.S. Bankruptcy Code; the risk that, if ADVENTRX liquidates its assets, the capital available for distribution ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

...Bec(R), the upcoming confirmatory Phase 3 protocol will be a highly powered, double-blind, randomized, placebo-controlled, multi-center trial and will seek to enroll an estimated 166 patients. The primary endpoint is the treatment failure rate at Study Day 80. This endpoint was successfully measured as a ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

...ibody blinatumomab (MT103) for acute lymphoblastic leukemia (ALL). Blinatumomab is a novel therapeutic antibody that activates a patient's T cells to seek out and destroy cancer cells. In June, Micromet announced that the company had achieved its primary endpoint in an ongoing Phase 2 study of ALL...

Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting

...on for the millions suffering from hair loss. Of the 87 million people in the United States that suffer from hair loss, it is estimated that only 2-7% seek surgical or pharmacological treatment. The same is true internationally due to the general lack of effective medical options for this widespread condi...

Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.

...DA, Md., July 23 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) today announces that it will seek shareholder approval for the Company to cancel its listing on the London Stock Exchange's AIM market ("AIM") (the "De-listing"). The Company plans to ...

QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

... reduced risk, abbreviated development paths, and improved patient outcomes. The Company intends to directly commercialise its products in the US and seek strategic partnerships abroad. QRxPharma's lead compound, MoxDuo(TM) IR , successfully completed a Phase 3 study and met primary and secondary endpoin...

Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer

...cutive level positions including sales management, corporate development and strategic marketing. His responsibilities included leading the effort to seek new technologies, evaluating new business opportunities for the U.S. diagnostic business, developing strategic investment and action plans to achieve ...

Cardium's InnerCool Therapies Business to Be Acquired By Royal Philips Electronics

... "We have made significant progress in developing best-in-class products and a portfolio of innovative product opportunities, and we will continue to seek additional partnering and valuation opportunities as our product opportunities and businesses advance." About Royal Philips Electronics ...

The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research

...better understand the unique aspects of WM biology and advance more effective treatments for WM patients." Under the agreement, LLS and IWMF will seek applications and select up to three laboratories to co-fund for up to $100,000 for one year. Continued funding, potentially for up to two additional ...

High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu

...gent filtration' technologies designed to combat the transmission of diseases. Using biochemistry at the molecular level, its proprietary technologies seek out dangerous pathogens and chemicals, from air, water, and from off surfaces - including the human skin, killing or inactivating them before they ent...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

...often diagnosed after a couple has not conceived after one year of unprotected, well-timed intercourse.(8) Women over the age of 35 are encouraged to seek diagnosis and treatment for infertility following six months of unprotected intercourse.(9) Around 15 percent of couples of reproductive age have a f...

Bion Announces Approval of New U.S. Patent that Broadens Protection for the Company's Livestock Waste Environmental Treatment Processes

...e system recovers cellulosic biomass from the waste stream to produce renewable energy in a process different and much more efficient than others that seek to exploit this energy source. The technology is scalable, proven and quickly gaining acceptance by regulatory agencies and other stakeholders as an e...

Pharmaxis Closes Share Purchase Plan

... information, future events or otherwise. We cannot guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors ...

ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009

...ta from its recently-completed bioequivalence study of ANX-514 and plans to seek a meeting with the FDA to discuss the results. For the near-term, the Comp... a timely basis to continue as a going concern; the risk that ADVENTRX will seek protection under the provisions of the U.S. Bankruptcy Code; the risk that ...

Cordex Completes Production of ATPace(TM) Clinical Trial Material

...itations, pounding in the chest, chest pressure or pain, weakness, shortness of breath, or dizziness. Unless it self-terminates, PSVT patients need to seek medical intervention to terminate the arrhythmia About Cordex Pharma , Inc. Cordex is a specialty pharmaceutical company that develops new...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

...nvest in the increased commercial resources needed to market the key advantages of our unique Gyrolab systems to both existing and new customers as we seek to drive our top-line growth." Gyrolab is a versatile, automated analytical platform that dramatically reduces the time required to optimize an...

B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices

...een, Senior Vice President and Chief Marketing Officer for B. Braun Medical Inc. "In developing these and all other B. Braun products, we continuously seek innovative ways to translate our customer's needs into products with unmatched quality, cost-effectiveness, environmental responsibility and safety." ...

Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

...ot been entered within 30 days of the interim order date. As indicated in the interim order, through the final DIP order process the DIP Lenders will seek "priming" liens to the extent that any parties possess secured claims against the Debtors. In connection with the Debtor's initial bankruptcy fil...

GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois

...be reached, (iv) Health System will request that the President of the CORE Foundation Board of Directors present the proposal to its Board in order to seek authorization to negotiate an agreement, (v) if an agreement is reached with CORE, whether needed funds can be raised, (vi) the proposed clinical tria...

Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

...commercial rights in the U.S. for Toraymyxin(TM), a therapeutic for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral will seek FDA approval for Toraymyxin(TM) and intends to commercialize the product together with EAA(TM). Spectral is listed on TSX under the symbol SDI. F...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

...s to drive the development and implementation of accurate and affordable diagnostic tests that can be used as near as possible to where patients first seek care. FIND's disease portfolio currently includes tuberculosis, malaria and human African trypanosomiasis and current donors are the Bill & Melind...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

...information, future events or otherwise. We can not guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

...ions in North America and Europe, respectively, to seek permission to initiate Phase I/II studies. Due to...t twelve months. The Company will continue to seek additional funding, primarily by way of equity off... the time of such financing. The Company may also seek additional funding from other sources, including t...

ADVENTRX Pharmaceuticals Announces Closing of Financing

...ly basis, certain terms of the offering announced on June 8, 2009 will prevent ADVENTRX from orderly winding-up its operations and require ADVENTRX to seek protection under the provisions of the U.S. Bankruptcy Code; the potential for regulatory authorities to require additional preclinical work and/or cl...

Assessment of safety and efficacy of human embryonic stem cell therapy

...fety and efficacy of our RPE cell therapy," stated William M. Caldwell IV, Chairman and CEO of ACTC. "We are now completing the finishing touches to seek FDA approval to conduct human clinical trials with a cell therapy that may be able to address many of the 200 plus known retinal diseases." ...